| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 9.6k | $18.91 | $181.4k | | 08/11/2023 |
| 08/11/2023 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 19.3k | $0.00 | $0 | | 08/11/2023 |
| 05/15/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 21.4k | $34.55 | $739.3k | | 02/02/2022 |
| 03/15/2023 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 7.3k | $30.65 | $224.7k | | 03/15/2023 |
| 03/09/2023 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 18.5k | $31.59 | $584.2k | | 09/22/2022 |
| 09/22/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 42.3k | $0.00 | $0 | | 09/22/2022 |
| 09/14/2022 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 11k | $27.07 | $297.8k | | 09/14/2022 |
| 03/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.2k | $15.79 | $35.2k | | 03/15/2022 |
| 03/15/2022 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.9k | $15.79 | $45.5k | | 03/15/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 68.1k | $13.08 | $890.7k | | 02/02/2022 |
| 02/02/2022 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 42.3k | $0.00 | $0 | | 02/02/2022 |
| 09/27/2021 | Revance Therapeutics, Inc. | RVNC | Sale | Common Stock | 1.7k | $30.00 | $50.2k | | 09/27/2021 |
| 03/15/2021 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 2.9k | $27.73 | $79.9k | | 03/15/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 19.3k | $0.00 | $0 | | 02/02/2021 |
| 02/02/2021 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 35k | $28.01 | $980.4k | | 02/02/2021 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Payment of Exercise | Common Stock | 4.2k | $25.14 | $106.5k | | 09/30/2020 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 12.2k | $0.00 | $0 | | 09/30/2020 |
| 02/18/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Employee Stock Option (Right to Buy) | 170k | $25.93 | $4.4M | | 02/18/2020 |
| 02/18/2020 | Revance Therapeutics, Inc. | RVNC | Grant | Common Stock | 25k | $0.00 | $0 | | 02/18/2020 |